Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Restructuring Costs: 2016-2018

Historic Restructuring Costs for Fortress Biotech (FBIO) over the last 2 years, with Sep 2018 value amounting to $1.7 million.

  • Fortress Biotech's Restructuring Costs fell 52.19% to $1.7 million in Q3 2018 from the same period last year, while for Sep 2018 it was $7.3 million, marking a year-over-year decrease of 3.91%. This contributed to the annual value of $8.8 million for FY2017, which is 2696.19% up from last year.
  • Latest data reveals that Fortress Biotech reported Restructuring Costs of $1.7 million as of Q3 2018, which was down 25.99% from $2.3 million recorded in Q2 2018.
  • Fortress Biotech's Restructuring Costs' 5-year high stood at $3.6 million during Q3 2017, with a 5-year trough of $315,000 in Q4 2016.
  • Moreover, its 3-year median value for Restructuring Costs was $1.8 million (2018), whereas its average is $1.9 million.
  • Its Restructuring Costs has fluctuated over the past 5 years, first spiked by 373.97% in 2017, then plummeted by 52.19% in 2018.
  • Quarterly analysis of 3 years shows Fortress Biotech's Restructuring Costs stood at $315,000 in 2016, then soared by 373.97% to $1.5 million in 2017, then crashed by 52.19% to $1.7 million in 2018.
  • Its Restructuring Costs was $1.7 million in Q3 2018, compared to $2.3 million in Q2 2018 and $1.8 million in Q1 2018.